VEGFC、ANGPT和EFNB2及其受体的诱导表达是增生型糖尿病视网膜病变新生血管化的特征
本研究采用高通量测序比较增生型糖尿病视网膜病变(PDR)新生血管膜与视网膜的全基因组转录差异,样本包括23例PDR或视网膜分支静脉阻塞患者、3份正常视网膜和2份II型糖尿病供体视网膜。结果显示新生血管膜中VEGFC、ANGPT1、ANGPT2、EFNB2及其受体FLT4、TIE1、TIE2、EPHB4过表达,而VEGFA在II型糖尿病视网膜中高表达、在新生血管膜中低表达;ETS1和ERG在新生血管膜中协同上调。作者据此提出PDR新生血管化模型,并提示潜在治疗靶点与生物标志物。
要点
- PDR新生血管膜的转录谱与视网膜不同,VEGFC、ANGPT1、ANGPT2、EFNB2及其受体FLT4、TIE1、TIE2、EPHB4过表达。
- VEGFA在II型糖尿病视网膜中高表达,但在新生血管膜中低表达。
- ETS1和ERG等血管生成转录因子在新生血管膜中协同上调,作者提出VEGFA驱动下游因子协同诱导新生血管的模型。
核心结论
- 本研究描述了一个PDR新生血管化模型:病理视网膜分泌的VEGFA增强一组血管生成转录因子和生长因子的表达,协同诱导视网膜新生血管化。
- 基于上述结果,作者提示了PDR治疗和诊断的新潜在治疗靶点与生物标志物。
研究设计与样本
- 研究采用高通量测序技术捕获所有参与者的全基因组基因表达水平,样本包括23例PDR或视网膜分支静脉阻塞(BRVO)患者、3份正常视网膜样本和2份II型糖尿病(T2D)供体眼视网膜样本。
- 随后用生物信息学方法分析表达模式,并通过原位杂交和Western blotting验证数据。
主要发现
- 新生血管膜(NVM)的转录谱与视网膜不同。
- 血管生成生长因子VEGFC、ANGPT1、ANGPT2、EFNB2及其相应受体FLT4、TIE1、TIE2、EPHB4过表达。
- VEGFA在T2D视网膜中高度上调,但在NVM中低表达。
- 包括ETS1和ERG在内的血管生成转录因子在NVM中协同上调。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate whole transcriptional differences between proliferative diabetic retinopathy (PDR) neovascular membranes (NVMs) and retinas, and the regulatory genes participating in retinal neovascularization in PDR. METHODS: We used high-throughput sequencing technology to capture the whole-genome gene expression levels of all participants, including 23 patients with PDR or branch retinal vein occlusion (BRVO), 3 normal retinal samples, and 2 retinal samples from type II diabetic (T2D) eyes by donation, followed by analyses of expression patterns using bioinformatics methods, then validation of the data by in situ hybridization and Western blotting. RESULTS: We showed that transcriptional profiles of the NVMs were distinct from those of the retinas. Angiogenesis growth factors VEGFC, ANGPT1, ANGPT2, and EFNB2, and their receptors FLT4, TIE1, TIE2, and EPHB4, respectively, were overexpressed. Expression of VEGFA was highly upregulated in T2D retina, but low in the NVMs, while angiogenesis transcription factors, including ETS1 and ERG, were coordinately upregulated in NVMs. CONCLUSIONS: This study described a PDR neovascularization model in which pathological retina-secreted vascular endothelial growth factor A (VEGFA) enhanced the expression of a set of angiogenesis transcription factors and growth factors, to cooperatively induce the retinal neovascularization. Based on these results, novel potential therapeutic targets and biomarkers for PDR treatment and diagnosis are suggested.
引用
- Li Y, Chen D, Sun L, et al. Induced Expression of VEGFC, ANGPT, and EFNB2 and Their Receptors Characterizes Neovascularization in Proliferative Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2019. PMID: 31574534. doi:10.1167/iovs.19-26767
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。